| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/23/2010 | US7666906 β-Benzyloxyaspartate derivatives with amino group on benzene ring |
| 02/23/2010 | US7666850 obtaining an epithelial cell sample suspected of being tumorigenic; identifying cells that have shed a 120-130 kD fragment of alpha -dystroglycan, presence of the fragment indicates that such cells are tumorigenic; contacting cell with a transfection agent containing a mammal dystroglycan gene |
| 02/23/2010 | US7666849 Ribosome structure and protein synthesis inhibitors |
| 02/23/2010 | US7666819 Integrated micro array system and methods therefor |
| 02/23/2010 | US7666817 Cellular libraries of peptide sequences (CLiPS) and methods of using the same |
| 02/23/2010 | US7666708 Doped elongated semiconductors, growing such semiconductors, devices including such semiconductors, and fabricating such devices |
| 02/23/2010 | US7666687 Miniaturized fluid delivery and analysis system |
| 02/23/2010 | US7666685 Screening method for identification of compounds suitable for treatment of oral cavity malodor associated with consumption of garlic |
| 02/23/2010 | US7666684 Determination of explosives including RDX |
| 02/23/2010 | US7666683 Rapid method of diagnosing a normal pregnancy with high accuracy |
| 02/23/2010 | US7666680 Using compressible semi-permeable membranes as tool in meassuring changes in osmotic pressure |
| 02/23/2010 | US7666679 Estimating concentration of carbon dioxide in geologic formation; enhanced oil recovery; peteroleum refining |
| 02/23/2010 | US7666671 tape impregnated with inactivated fixative, which is removed from slide after fixative is activated |
| 02/23/2010 | US7666670 Animal model for the fast identification of pharmaceutical active compounds in vivo |
| 02/23/2010 | US7666663 Method for correcting the influence of intensity distribution (shading) of a light source (excitation light) in the scan-less type biochip reader in which a wide biochip range is measured simultaneously with a plurality of light beams |
| 02/23/2010 | US7666662 Chemical reaction device, chemical reaction system and chemical reaction method |
| 02/23/2010 | US7666651 Polypeptide having heparanase activity |
| 02/23/2010 | US7666646 Crystal structure of human Pim-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design |
| 02/23/2010 | US7666642 Nematode fatty acid desaturase-like sequences |
| 02/23/2010 | US7666621 Has an apparent molecular weight of 42,000 Daltons; fusion protein of the protein D bound to a polypeptide, carbohydrate, or matrix; prepared by providing a non-human host containing a plasmid or phage comprising a DNA nucleotide sequence and expressing the encoded protein D |
| 02/23/2010 | US7666619 Compounds and methods for regulating bacterial growth and pathogenesis |
| 02/23/2010 | US7666614 Determining presence or absence of the antigen in the sample by a signal formed by the binding of the antigen-indicator labeling reagent complex to an indicator capture reagent specific for antigen-indicator labeling reagent complex |
| 02/23/2010 | US7666613 psychiatric disorders; serine protease; genetic engineering; schizophrenia |
| 02/23/2010 | US7666612 Methods for protein labeling based on acyl carrier protein |
| 02/23/2010 | US7666611 Lysophosphatidic acid receptor |
| 02/23/2010 | US7666610 Expressing transporters on viral envelopes |
| 02/23/2010 | US7666609 Method and composition for diagnosis of melanocytic lesions |
| 02/23/2010 | US7666608 Determining ratio of expression levels of serum amyloid A1 (SAA1) gene and serum amyloid A2 (SAA2) gene; steroid treatment prognosis; tumor necrosis factor inhibitors |
| 02/23/2010 | US7666607 tumor necrosis factor receptors; drug screening modulators of jun n-terminal kinase and nuclear factor kappa beta |
| 02/23/2010 | US7666606 Protein- protein interaction detection system using fluorescent protein microdomains |
| 02/23/2010 | US7666605 Method for prognostic evaluation of carcinoma using anti-P-LAP antibody |
| 02/23/2010 | US7666604 Modified soluble T cell receptor |
| 02/23/2010 | US7666603 Breast cancer related protein, gene encoding the same, and method of diagnosing breast cancer using the protein and gene |
| 02/23/2010 | US7666601 Membrane protein; point mutations; antibodies; food processing and bitterness; phenotype analysis |
| 02/23/2010 | US7666595 Biomarkers for predicting prostate cancer progression |
| 02/23/2010 | US7666594 biosensors; cationic polymers; peptide nucleic acids; point mutations; quantitative analysis |
| 02/23/2010 | US7666586 Such as urinary bladder tissue; immunoassays |
| 02/23/2010 | US7666584 analyzing ATP-binding cassette transporter 5 polypeptide levels; ELISA |
| 02/23/2010 | US7666583 Identification of cancer protein biomarkers using proteomic techniques |
| 02/23/2010 | US7666582 Immunoglobulin G-degrading enzyme for use as tool in diagnosis, prevention and treatment of streptococcal infection |
| 02/23/2010 | US7666478 Applying alternative voltage difference between electrodes, generating and maintaining cold atmospheric pressure plasma in volumetric space between, and depositing coating on surface to immobilize |
| 02/23/2010 | US7666441 Nucleic acids encoding peptides having at least one biological activity of Can f I or Can f II, protein allergens of the species Canis familiaris; suitable for pharmaceutical administration or methods of diagnosing sensitivity to dog dander |
| 02/23/2010 | US7666432 Suppressing fibrosis in a mammal having a fibrosing disease by administering a Serum Amyloid P (SAP) protein; treatment of diseases such as scleroderma, pulmonary fibrosis and asthma |
| 02/23/2010 | US7666429 Nucleic acids encoding a house dust mite allergen Der P III, and uses therefor |
| 02/23/2010 | US7666425 Use of antibodies or binding portions thereof, probes, ligands, or other biological agents which either recognize an extracellular domain of prostate specific membrane antigen or bind to and are internalized with prostate specific membrane antigen |
| 02/23/2010 | US7666418 Method for treating Th2-mediated disease |
| 02/23/2010 | US7666415 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 02/23/2010 | US7666411 Administering to the subject an effective amount of a substance that binds to IL-13, wherein the substance that binds to IL-13 is an antibody and inhibits IL-13 activation of IL-13R alpha |
| 02/23/2010 | US7666401 Compositions comprising a ligand of Chemerin R |
| 02/23/2010 | US7666393 Methods for assessing antiangiogenic agents |
| 02/23/2010 | US7666391 Therapeutic treating breast cancer |
| 02/23/2010 | US7666389 Method of imaging cell death in vivo |
| 02/23/2010 | US7666308 Magnetic separation apparatus and methods |
| 02/23/2010 | US7665344 Test device for internal combustion engine |
| 02/23/2010 | US7665303 Method of segregating a bolus of fluid using a pneumatic actuator in a fluid handling circuit |
| 02/23/2010 | CA2559723C Fluorescence polarization assay related applications |
| 02/23/2010 | CA2428641C Functional fragment of the leptin receptor |
| 02/23/2010 | CA2416949C Non-human animal model unresponsive to mycoplasma derived lipoprotein/lipopeptide |
| 02/23/2010 | CA2380019C Use of 13c nmr spectroscopy to produce optimum fischer-tropsch diesel fuels and blend stocks |
| 02/23/2010 | CA2355834C Human akt-3 |
| 02/23/2010 | CA2347618C Blood processing systems and methods with sensors to detect contamination |
| 02/23/2010 | CA2331742C Methods for quantitating low level modifications of nucleotide sequences |
| 02/23/2010 | CA2268339C Compositions and methods for detection of antibody binding to cells |
| 02/23/2010 | CA2232288C Treating niddm with rxr agonists |
| 02/23/2010 | CA2198731C Assay and reagent kit for the quantitative in vitro determination in biological specimens of the activity of proteins causing multi-drug resistance in tumors |
| 02/23/2010 | CA2161958C Method and apparatus for semi-automated cell separation |
| 02/23/2010 | CA2138999C Cloning and expression of gonadotropin-releasing hormone receptor |
| 02/18/2010 | WO2010019960A2 Flow cytometry-based systems and methods for detecting microbes |
| 02/18/2010 | WO2010019920A2 Porous materials for biological sample collection |
| 02/18/2010 | WO2010019878A1 Methods for identifying compounds which inhibit binding of anthrax protein to lrp5/6 receptors. |
| 02/18/2010 | WO2010019874A1 Methods of predicting the risk of recurrence of cancer |
| 02/18/2010 | WO2010019811A2 Methods for screening for modulators of ccrl2 |
| 02/18/2010 | WO2010019725A2 Node polypeptides for nanostructure assembly |
| 02/18/2010 | WO2010019566A2 Methods for determining levels of 1,25 dihydroxy vitamin d2 and d3 |
| 02/18/2010 | WO2010019553A2 Biomarker detection process and assay of neurological condition |
| 02/18/2010 | WO2010019519A2 Method of using foxo3a polymorphisms and haplotypes to predict and promote healthy aging and longevity |
| 02/18/2010 | WO2010019515A2 Digital light processing hyperspectral imaging apparatus |
| 02/18/2010 | WO2010019420A1 Non-hypergeometric overlap probability |
| 02/18/2010 | WO2010019414A2 Detecting nucleic acid |
| 02/18/2010 | WO2010019388A2 Method and apparatus for the discretization and manipulation of sample volumes |
| 02/18/2010 | WO2010019372A1 Reference control for cell by cell analysis |
| 02/18/2010 | WO2010019317A2 System and method for collecting plasma protein fractions from separated blood components |
| 02/18/2010 | WO2010019227A1 Ex vivo therapeutic screening of living bone marrow cells for multiple myeloma |
| 02/18/2010 | WO2010019041A1 Methods and devices for assessment of mitochondrial function |
| 02/18/2010 | WO2010018870A1 Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis |
| 02/18/2010 | WO2010018859A1 Modified biotin-binding protein |
| 02/18/2010 | WO2010018840A1 Probe for visualizing nerve activity |
| 02/18/2010 | WO2010018833A1 Blood-platelet test method and blood-platelet test device |
| 02/18/2010 | WO2010018764A1 Anti-angiogenic agent, and screening method and screening kit for same |
| 02/18/2010 | WO2010018731A2 A mammalian rna dependent rna polymerase |
| 02/18/2010 | WO2010018545A1 Detection and use of pheromones |
| 02/18/2010 | WO2010018499A1 Apparatus and method for performing cellular susceptibility testing |
| 02/18/2010 | WO2010018489A1 Apparatus and method for a microfluidic system for creating a concentration gradient |
| 02/18/2010 | WO2010018460A1 Fluorescent emulsion |
| 02/18/2010 | WO2010018413A2 Detection method |
| 02/18/2010 | WO2010018394A1 Calibration solution packaging method and calibration solution package |
| 02/18/2010 | WO2010018375A1 Preparation of biological samples for compound-specific carbon isotope analysis |
| 02/18/2010 | WO2010018363A1 Methods for measurement of fluid electrical stability |
| 02/18/2010 | WO2010018348A2 Device for identifying and automatically paying for agri-food or pharmaceutical products through optical recognition |
| 02/18/2010 | WO2010018285A1 Methods and kits for quantification of the concentration of anionic surfactants in water or aqueous media |